Showing results (1241-1250 of 2,812) with videos related to
Sort By:
Pageof 282
Expert Opinion on Drug Safety|August 3, 2018
The safety of empagliflozin plus metformin for the treatment of type 2 diabetesAndré J ScheenExpert Opinion on Drug Safety|July 12, 2018
A narrative review of problems with medicines use in people with dementiaTesfahun C Eshetie, Tuan A Nguyen, Marianne H Gillam, et al.Expert Opinion on Drug Safety|December 24, 2005
Toxicity of infliximab in the course of treatment of Crohn's diseaseJason M Bratcher, Burton I KorelitzExpert Opinion on Drug Safety|August 22, 2018
Cardiovascular safety of oncologic agents: a double-edged sword even in the era of targeted therapies - Part 2Antonis A Manolis, Theodora A Manolis, Dimitri P Mikhailidis, et al.Expert Opinion on Drug Safety|August 24, 2018
An overview of properties of Amphora (Acidform) contraceptive vaginal gelAnita L NelsonExpert Opinion on Drug Safety|September 1, 2018
Safety and tolerability profile of new antiepileptic drug treatment in children with epilepsyRomina Moavero, Laura Rosa Pisani, Francesco Pisani, et al.Expert Opinion on Drug Safety|August 16, 2018
Measuring the impact of the 2012 European pharmacovigilance legislation on additional risk minimization measuresReynold D C Francisca, Inge M Zomerdijk, Miriam C J M Sturkenboom, et al.Expert Opinion on Drug Safety|September 21, 2016
Proton pump inhibitors and risk of Clostridium difficile infection: a multi-country study using sequence symmetry analysisElizabeth E Roughead, Esther W Chan, Nam-Kyong Choi, et al.Expert Opinion on Drug Safety|May 4, 2017
Risk of gastrointestinal bleeding during anticoagulant treatmentAitor Lanas-Gimeno, Angel LanasExpert Opinion on Drug Safety|June 3, 2017
The safety and tolerability of nintedanib in the treatment of idiopathic pulmonary fibrosisVincent CottinPageof 282